These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

711 related items for PubMed ID: 9396371

  • 1. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
    Matsumoto F, Uzuki M, Kaneko C, Rikimaru A, Kokubun S, Sawai T.
    Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
    [Abstract] [Full Text] [Related]

  • 2. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y, Koda M, Murawaki Y.
    Res Commun Mol Pathol Pharmacol; 2004 Oct; 115-116():143-50. PubMed ID: 17564313
    [Abstract] [Full Text] [Related]

  • 3. [Expression of urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR) plays a role in destruction of joint tissue in rapidly destructive coxarthropathy (RDC)].
    Tamura N, Uzuki M, Matsumoto F, Rikimaru A, Kokubun S, Sawai T.
    Ryumachi; 2001 Oct; 41(5):851-7. PubMed ID: 11729663
    [Abstract] [Full Text] [Related]

  • 4. Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip.
    Masuhara K, Nakai T, Yamaguchi K, Yamasaki S, Sasaguri Y.
    Arthritis Rheum; 2002 Oct; 46(10):2625-31. PubMed ID: 12384920
    [Abstract] [Full Text] [Related]

  • 5. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T, Okada Y, Nakanuma Y.
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [Abstract] [Full Text] [Related]

  • 6. Matrix metalloproteinases and their inhibitors.
    Kugler A.
    Anticancer Res; 1999 Jun; 19(2C):1589-92. PubMed ID: 10365151
    [Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M, Kuboki T, Kojima S, Fujisawa T, Hattori T, Takigawa M, Yamashita A.
    J Orofac Pain; 2000 Jun; 14(1):20-30. PubMed ID: 11203734
    [Abstract] [Full Text] [Related]

  • 8. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y.
    Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
    [Abstract] [Full Text] [Related]

  • 9. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
    Takagi M, Santavirta S, Ida H, Ishii M, Akimoto K, Saotome K, Konttinen YT.
    Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
    [Abstract] [Full Text] [Related]

  • 10. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N.
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
    Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D.
    Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
    Sugiura Y, Shimada H, Seeger RC, Laug WE, DeClerck YA.
    Cancer Res; 1998 May 15; 58(10):2209-16. PubMed ID: 9605768
    [Abstract] [Full Text] [Related]

  • 13. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
    Webster L, Chignell AH, Limb GA.
    Exp Eye Res; 1999 Jan 15; 68(1):91-8. PubMed ID: 9986746
    [Abstract] [Full Text] [Related]

  • 14. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct 15; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 15. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA, Danning CL, Illei GG, El-Gabalawy HS, Boumpas DT.
    J Rheumatol; 2002 Jan 15; 29(1):107-17. PubMed ID: 11824946
    [Abstract] [Full Text] [Related]

  • 16. A study of metalloproteinases in fifty joint fluid specimens.
    Gaudin P, Razakaboay M, Surla A, Berthier S, Fauconnier J, Morel F, Phelip X.
    Rev Rhum Engl Ed; 1997 Jun 15; 64(6):375-81. PubMed ID: 9513609
    [Abstract] [Full Text] [Related]

  • 17. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
    Papakonstantinou E, Dionyssopoulos A, Aletras AJ, Pesintzaki C, Minas A, Karakiulakis G.
    J Am Acad Dermatol; 2004 Oct 15; 51(4):526-33. PubMed ID: 15389186
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
    Hayashi T, Stetler-Stevenson WG, Fleming MV, Fishback N, Koss MN, Liotta LA, Ferrans VJ, Travis WD.
    Am J Pathol; 1996 Oct 15; 149(4):1241-56. PubMed ID: 8863673
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
    Afzal S, Lalani el-N, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M, Stamp GW.
    Lab Invest; 1996 Feb 15; 74(2):406-21. PubMed ID: 8780160
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
    Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, Turner AR, Zhang MC, Edwards DR, Kossakowska AE.
    Br J Haematol; 1999 May 15; 105(2):402-11. PubMed ID: 10233411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.